DUBLIN, May 12, 2022--(BUSINESS WIRE)--The "Global Sulfadiazine Sodium Injection Market 2021-2027" report has been added to ResearchAndMarkets.com's offering.
The global sulfadiazine sodium market is anticipated to grow at a considerable CAGR during the forecast period.
Increasing awareness of safe antibiotic use is likely to create high demand for sulfadiazine sodium injection in the global market, owing to widespread antibiotic resistance. Sulfadiazine is an antibacterial prescription drug approved by the US Food and Drug Administration (FDA) for the treatment of chancroid, Toxoplasma gondii encephalopathy, urinary tract infections, and other bacterial diseases.
The global sulfadiazine sodium market is segmented based on product type and end-user. Based on product type, the sulfadiazine sodium market is segmented into 20 Mg/Ml, 40 Mg/Ml, and others. Based on end-user, the sulfadiazine sodium market is segmented into hospitals, clinics, medical centers, and veterinary.
Geographically, the global sulfadiazine sodium market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global sulfadiazine sodium market include Sichuan Chengkang, XINHUA PHARM, Square Pharmaceuticals, Jurox, Pfizer among others.
Global Sulfadiazine sodium Market Research and Analysis by Product Type
Global Sulfadiazine sodium Market Research and Analysis by End-User
Comprehensive research methodology of the global sulfadiazine sodium market.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global sulfadiazine sodium market.
Insights about market determinants that are stimulating the global sulfadiazine sodium market.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.
2.2. Analyst Insight & Current Market Trends
4.1. Global Sulfadiazine Sodium Market by Product Type
4.2. Global Sulfadiazine Sodium Market by End-User
For more information about this report visit https://www.researchandmarkets.com/r/ze6ei3
View source version on businesswire.com: https://www.businesswire.com/news/home/20220512005567/en/
ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Do you have the right portfolio for your retirement savings? When it comes to long-term investing, the biggest issue — by far — is overall asset allocation: How much to stocks, sectors, assets and so on. Picking individual securities within those asset classes — individual stocks or bonds, for example — usually turns out to be much less important.
Meanwhile, things are even worse for the growth-dependent Nasdaq Composite (NASDAQINDEX: ^IXIC). Following its all-time high in November 2021, the Nasdaq has tumbled 27%. The Nasdaq's tumble officially places it in a bear market.
A Friday rally saves the S&P 500 from a technical bear market, but leaves questions hanging: How long will this last, and will it end in recession?
Entering the final day of trading this week, the stock of Chinese electric vehicle maker Nio (NYSE: NIO) had been down more than 12% just this week, and more than 25% over the past month. After rising more than 9% Friday morning, Nio American depositary shares (ADSs) were still up 7.1% as of 10:50 a.m. ET. There are fears the U.S.-listed ADSs could be delisted as the company joined a growing list of Chinese names that will be required to provide proof of meeting U.S. accounting and audit standards for three straight years.
Feel poorer after the S&P 500's sell-off? Just know it could be worse. Much worse. Investors who piled in some $40 billion firms found out.
(Bloomberg) -- An investment firm for the Walton family ramped up its position in a U.S. municipal bond fund and added a sizable stake in Japanese equities, while also betting on small-cap stocks and Coinbase Global Inc. before tumultuous declines. Most Read from BloombergElon Musk Sows Doubt Over His $44 Billion Twitter TakeoverIndia Bans Wheat Exports as Food Security Comes Under ThreatSony PlayStation Staff Fume Over CEO’s Abortion CommentsApple Testing iPhones That Ditch Lightning Ports in F
In this article, we will discuss the 12 best energy stocks for 2022. If you want to skip our detailed analysis of the energy sector which highlights key trends and major players, you can go directly to 5 Best Energy Stocks for 2022. The energy sector has been the biggest contributor to skyrocketing inflation in […]
Warren Buffett has guided Berkshire Hathaway to market-crushing returns through good times and bad, and the Oracle of Omaha's investment conglomerate has now posted a total return of roughly 3.5% year to date. With a tip of the hat to Buffett's impressive market-beating mojo, a panel of Motley Fool investors has identified a trio of great stocks in the Berkshire portfolio that have what it takes to deliver fantastic performance. Read on to see why they identified Amazon (NASDAQ: AMZN), Kroger (NYSE: KR), and Apple (NASDAQ: AAPL) as stocks that can help you crush the market over the long term.
Where do millionaires keep their money? High net worth individuals put money into different classifications of financial and real assets, including stocks, mutual funds, retirement accounts and real estate. Most of the 20.27 million millionaires in the U.S. did not … Continue reading → The post Where Do Millionaires Keep Their Money? appeared first on SmartAsset Blog.
Micron could be the cheapest tech stock in the market, based on its price/earnings ratio. Western Digital isn’t far behind.
A rally attempt is underway. Get ready, get set, but don't go just yet. Chevron, Broadcom, Tesla and Twitter are among stocks to watch.
Friday's mini-rally notwithstanding, it’s getting ugly out there. Bottom line: The market may shoot back up anytime, but this doesn’t feel like a plain-vanilla dip
(Bloomberg) -- The week is ending on a higher note for Big Tech on hopes a relentless selloff may be nearing exhaustion. But Friday’s rally can’t completely wipe out a sobering signal from Apple Inc. shares. Most Read from BloombergElon Musk Sows Doubt Over His $44 Billion Twitter TakeoverIndia Bans Wheat Exports as Food Security Comes Under ThreatSony PlayStation Staff Fume Over CEO’s Abortion CommentsApple Testing iPhones That Ditch Lightning Ports in Favor of USB-CTerra $45 Billion Face Plant
The digital banking company has gotten crushed this year along with many other tech and fintech stocks.
We've seen this movie before only to watch dip-buyers get fleeced — but money managers are now warming to the idea of a material bounce in stocks.
These blue chip stocks can generate steady passive income in even the most challenging environments.
After reaching $3 trillion in November, the market value of the crypto market has fallen to $1.37 trillion.
In my April 28th Real Money column, I wrote a heartfelt letter to Elon Musk imploring him to walk away from Twitter . Musk followed that with a tweet two hours later stating that he "was still committed to the transaction." The threads of Elon's Twitter bid have been laid bare for the past two weeks.
Shares of Boeing (NYSE: BA) joined the rally on Friday morning, trading up more than 6% at one point, only to give up most of those gains as they day went on. Investors got a reminder of the challenges that face Boeing's commercial division, taking the wind out of the shares. It's been a tough run for Boeing, with shares down by more than 60% since the start of 2020.
Our call of the day from Thomas Kee Jr. is pounding the table over the importance of volatility, but says investors need to not just fear the lows, but embrace the highs.